Recent Updates
Recently added Catalysts
QGEN Positive Sentiment

QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction

Thursday, August 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QIAGEN has launched QIAsymphony Connect, an IVD-compliant platform designed for automated clinical nucleic acid extraction. This new platform aims to standardize extraction processes across various assay workflows in clinical laboratories. Leveraging the success of the existing QIAsymphony platform, it promises to enhance efficiency and reliability in nucleic acid extraction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of QIAsymphony Connect enhances clinical lab efficiency.
  • The platform is IVD-compliant, ensuring regulatory standards.
  • It builds on a trusted platform with over 3,300 placements worldwide.

Full Press Release Details

VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Building on the trusted QIAsymphony platform, with more than 3,300 cumulative placements worldwide, QIAsymphony Connect helps clinical laboratories standardize extraction across diverse assay workflows. The platform delivers highly concentrated DNA and

Frequently Asked Questions

What is QIAsymphony Connect?

QIAsymphony Connect is an IVD-compliant platform for automated clinical nucleic acid extraction.

How does QIAsymphony Connect benefit laboratories?

It helps standardize extraction processes across diverse assay workflows in clinical labs.

How many QIAsymphony platforms are in use?

There are over 3,300 cumulative placements of the QIAsymphony platform worldwide.

Is QIAsymphony Connect compliant with regulations?

Yes, it is an IVD-compliant platform, meeting regulatory standards.

ShareAdd on Google
Tags: QGEN Viatris Investor Conferences Healthcare QIAGEN nucleic acid extraction clinical laboratories IVD-compliant automation
Last updated: Aug 27, 2026

Biotech snapshot

Lead asset
NEU-411Phase 2
Parkinson Disease →